Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Tracon Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 25.1K | $3.46K | $0.14 | Apr 20, 2023 | Direct |
Tracon Pharmaceuticals, Inc. | CHIEF FINANCIAL OFFICER | Employee Stock Option (Right to Buy) | 225K | Mar 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TCON | Tracon Pharmaceuticals, Inc. | Mar 12, 2024 | 2 | $482 | 4 | Mar 13, 2024 | CHIEF FINANCIAL OFFICER |
TCON | Tracon Pharmaceuticals, Inc. | Feb 1, 2023 | 1 | $0 | 4 | Feb 3, 2023 | Chief Financial Officer |
TCON | Tracon Pharmaceuticals, Inc. | Dec 29, 2022 | 1 | $5.22K | 4 | Jan 3, 2023 | Chief Financial Officer |
TCON | Tracon Pharmaceuticals, Inc. | Sep 12, 2022 | 1 | $5.04K | 4 | Sep 14, 2022 | Chief Financial Officer |
TCON | Tracon Pharmaceuticals, Inc. | Mar 29, 2022 | 1 | $2.82K | 4 | Mar 30, 2022 | Chief Financial Officer |
TCON | Tracon Pharmaceuticals, Inc. | Jan 28, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Financial Officer |
TCON | Tracon Pharmaceuticals, Inc. | Aug 13, 2021 | 1 | $3.69K | 4 | Aug 17, 2021 | Chief Financial Officer |